Breaking News, Promotions & Moves

Alcami Names Patrick D. Walsh as Chairman and CEO

35-year pharmaceutical industry veteran brings deep industry expertise and a track record of building successful, client-centric, growth organizations.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Alcami, a global pharmaceutical CDMO, has appointed Patrick D. Walsh as chairman and chief executive officer, effective immediately. He succeeds Walter J. Kaczmarek III, who is stepping down as chief executive. Prior to joining Alcami, Mr. Walsh was co-founder and chief executive officer of TriPharm Services, a parenteral manufacturing business that was acquired by Alcami in January 2020. From 2015 to 2019, Mr. Walsh was the chief executive officer of Avista Pharma, a private equity-backed glob...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters